Herbal medicines - Evidence and drug interactions in clinical practice;Naturlægemidler - Evidens og lægemiddelinteraktioner i klinisk praksis

Ugeskrift for Laeger

Volumn 164, Issue 36, 2002, Pages 4161-4165

  Kistorp, Thomas Klint ^a   Laursen, Søren Bjørn ^a  

^a NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CYCLOSPORIN; DIGOXIN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; HYPNOTIC AGENT; INDINAVIR; THEOPHYLLINE; VALERIAN; WARFARIN; PLANT EXTRACT;

CLINICAL PRACTICE; DIETARY INTAKE; DRUG INDUCED DISEASE; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; GARLIC; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; REVIEW; CONTROLLED CLINICAL TRIAL; DRUG INTERACTION; HERB DRUG INTERACTION; HYPERICUM; MEDICINAL PLANT; METABOLISM; PHYTOTHERAPY; PRACTICE GUIDELINE;

CONTROLLED CLINICAL TRIALS; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; GARLIC; GINKGO BILOBA; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PRACTICE GUIDELINES; VALERIAN;

EID: 2242474827     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Sundhedsministeriets bekendtgørelse 1992-09-21 nr. 790 om naturlægemidler.
2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569-75.
3. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 2000; 97: 7500-2.
4. Linde K, Mulrow CD. St John's wort for depression (Cochrane Review). I: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.
5. Karliova M, Treichel U, Malago M, Frilling A, Gerken G, Broelsch CE.Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 2000; 33: 853-5.
6. Mai I, Kruger H, Budde K, Johne A, Brockmoller J, Neumayer HH et al. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther 2000; 38: 500-2.
7. Ruschitzka F, Meier PJ, Turina M, Lüscher TF, Georg Noll. Acute heart transplant rejection due to Saint John's wort. Lancet 2000; 355: 548-9.
8. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338-45.
9. Jensen K. Perikoninteraktioner. Ugeskr Læger 2000; 162: 2062.
10. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-8.
11. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME et al. Effectiveness of St John's wort in major depression: A randomized controlled trial. JAMA 2001; 285: 1978-86.
12. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286: 208-16.
13. Chung KF, Dent G, McCusker M, Guinot P, Page CP, Barnes PJ. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet activating factor in man. Lancet 1987; 1: 248-51.
14. Logani S, Chen MC, Tran T, Le T, Raffa RB. Actions of Ginkgo biloba related to potential utility for the treatment of conditions involving cerebral hypoxia. Life Sci 2000; 67: 1389-96.
15. Ernst E, Pittler MH. Ginkgo biloba for dementia: A systematic review of double-blind, placebo-controlled trials. Clin Drug Inv 1999; 17: 301-8.
16. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: A meta-analysis of randomized trials. Am J Med 2000; 108: 276-81.
17. Jensen K. Risici ved indtagelse af kosttilskud, naturmedicin og urtete. Ugeskr Læger 1999; 161: 2692-6.
18. Leathwood PD, Chauffard F, Heck E, Munoz-Box R. Aqueous extract of valerian root (Valeriana officinalis L) improves sleep quality in man. Pharmacol Biochem Behav 1982; 17: 65-71.
19. Lindahl O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav 1989; 32: 1065-6.
20. Dorn M. Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: A randomised, double-blind, clinical, comparative study. Forschende Komplementarmedizin und Klassische Naturheilkunde 2000; 7: 79-84.
21. Leuschner J, Miiller J, Rudmann M. Characterisation of the central nervous depressant effect of a commercially available valerian root extract. Arzneimittelforschung 1993; 43: 638-41.
22. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998; 280: 77.
23. Klepser TB, Klepser ME. Unsafe and potentialy safe herbal therapies. Am J Health-Syst Pharm 1999; 56: 125-38.
24. Silagy C, Neil A. Garlic as a lipid lowering agent - A meta analysis. J R Coll Physicians Lond 1994; 28: 39-45.
25. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A meta analysis. Ann Intern Med 1993; 119: 599-605.
26. Mar C, Bent S. An evidence-based review of the 10 most commonly used herbs. West J Med 1999; 171: 168-71.
27. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia: A meta-analysis of randomised clinical trials. Ann Intern Med 2000; 133: 420-9.
28. Silagy CA, Neil H. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12: 463-8.
29. Bordia A. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978; 30: 355-60.
30. Koscielny J, Klussendorf D, Latza R, Schmitt R, Radtke H, Siegel G et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis 1999; 144: 237-49.
31. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneus spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion. Neurosurgery 1990; 26: 880-2.
32. Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise. Clin Ther 1991; 13: 373-82.
33. D'Angelo L, Grimalidi R, Caravaggi M, Marcoli M, Perucca E, Lecchini S et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol 1986; 16: 15-22.
34. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995; 18: 1373-5.
35. Punnonen R, Lukola A. Oestrogen-like effect of ginseng. BMJ 1980; 281: 1110.
36. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol 1988; 159: 1121-2.
37. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health-Syst Pharm 1997; 54: 692-3.
38. Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: Face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998; 45: 496-500.